Investment Banking Leadership Team

Matt Clark
Managing Director, Chief Operating Officer, Investment Banking

Mr. Clark is a Managing Director and Chief Operating Officer within BTIG's Investment Banking Group. Prior to joining BTIG, Mr. Clark was a Managing Director of Corporate and Venture Services at ThinkEquity Partners LLC, where he developed a venture capital community calling effort for the execution of private and public capital market transactions. Previously, Mr. Clark ran the Special Equities Group at Silicon Valley Bank Securities (SVB), where he served as a Managing Director and drove the development of a broker-dealer platform to service all the capital markets needs of the bank's client base. Previously, he was a Managing Director responsible for the Special Situations desk at Banc of America Securities, where he managed all transactions originating out of firm-wide Private Equity/Venture Capital coverage efforts across the Global Commercial Investment Bank (GCIB). Mr. Clark has over 20 years of experience managing transactions for growth companies. He received his B.A. in History from UC Berkeley.

David Fullerton
Managing Director, Head of Equity-Linked Capital Markets

Mr. Fullerton is a Managing Director and Head of Equity-Linked Capital Markets within BTIG's Investment Banking Group. He leads the firm's convertible capital markets activities, and manages BTIG's relationship with energy and financial clients. Prior to joining BTIG, Mr. Fullerton was a Managing Director at JMP Securities, where he built the firm's convertible, registered direct and private capital markets businesses and was a member of their Commitment Committee. Previously, he held similar positions at Piper Jaffray and Robertson Stephens. Mr. Fullerton has completed more than 80 private and public equity, convertible and 144A offerings, and has raised more than $2.5 billion in new funding for corporate clients in a wide variety of industries. Earlier in his career, he was responsible for Bank of America's U.S. Agency and Mortgage-Back Trading Desks, and Institutional and Retail Fixed Income Sales Groups. Mr. Fullerton started his career at Bank of America in the U.S. corporate credit and lending divisions. He is a graduate of Princeton University and has an M.B.A. in Finance from MIT.

Colin Knudsen
Managing Director, Technology, Media and Telecommunications (TMT) Investment Banking

Mr. Knudsen is a Managing Director within BTIG's Technology, Media and Telecommunications Investment Banking Group. Prior to BTIG, he was a Co-Founder and Vice Chairman of Coady Diemar Partners, a boutique M&A and private capital advisory firm. Earlier in his career, Mr. Knudsen served as a Managing Director within the Technology, Media and Telecommunications Investment Banking Groups at Credit Suisse, and as a Managing Director within the Media and Communications Group at Donaldson, Lufkin & Jenrette (DLJ), where he served for nearly 20 years. He also served as Co-Head of the Internet Infrastructure/Data Services groups of both firms, and was a member of the Investment Committees of the DLJ New Economy Fund and the DLJ Fund of Funds. Mr. Knudsen was a two-time recipient of DLJ's Super Achiever Award. He earned an M.B.A. from Columbia University, and an undergraduate degree in international relations from Brown University.

Charles Mather, CFA
Managing Director, Head of Equity Capital Markets

Mr. Mather is a Managing Director and Head of Equity Capital Markets within BTIG's Investment Banking Group. Prior to joining BTIG, he was the Co-Head of Equity Capital Markets and Head of the Private and Alternative Capital Group at Janney Montgomery Scott. Previously, he served as Managing Director and Head of the Structured Equity Group at Jefferies. Earlier in his career, Mr. Mather was with Cowen and Company for ten years, where he led the Private Equity Group. He also held senior investment and investment banking positions at Smith Barney Inc. and Prudential Investment Corporation. Mr. Mather has completed advisory and financing assignments for more than 100 companies. He received an M.B.A. in finance from The Wharton School, University of Pennsylvania and an A.B. from Brown University. Mr. Mather is also a Chartered Financial Analyst.

Gene Ramirez
Managing Director, Technology, Media and Telecommunications (TMT) Investment Banking
Mr. Ramirez is a Managing Director within BTIG's TMT Investment Banking Group. With over 20 years of industry experience, he has a strong combination of investment banking, operational and strategic expertise. Before joining BTIG, he was Head of the Technology, Media and Telecommunications Group at Morgan Joseph TriArtisan. Previously, Mr. Ramirez held various management positions at Robertson Stephens & Co. in San Francisco, California, and Southwest Securities in Dallas, Texas. He has founded two software companies, one of which was sold to Oracle in 2002. Mr. Ramirez has advised technology clients on more than 80 public and private financings, and mergers and acquisitions, representing over $10 billion in transaction value. He has advised a broad spectrum of technology companies over the last 20 years, and has a deep background in the technology industry, primarily focused on growth companies. Mr. Ramirez received an M.B.A. with a concentration in Entrepreneurship from the Franklin W. Olin Graduate School of Business at Babson College, and a B.A. in Economics with a specialization in Finance from the University of Texas at Austin.

Mark Secrest
Managing Director, Healthcare Investment Banking

Mr. Secrest is a Managing Director within BTIG's Healthcare Investment Banking Group, focused on medical devices, life sciences tools and diagnostics companies. He has over 25 years of investment banking experience, most recently as a Managing Director and Head of Medical Devices M&A within the Healthcare Investment Banking Group at Stifel. Prior to Stifel, Mr. Secrest served in a number of roles at Cowen between 1998 and 2010, including Head of Medical Technology M&A and Chairman of the Fairness Opinion Review Committee. Between 1995 and 1998, he was a Director within the M&A Group at UBS Securities. At UBS, Mr. Secrest was instrumental in the development and growth of a start-up M&A effort, and a member of the group responsible for the execution of the firm's M&A assignments involving North American clients outside of financial institutions. He ?began his career in the M&A Group at Kidder, Peabody. Mr. Secrest holds a B.A. from Stanford University, and an M.B.A. from the Stern School of Business at New York University.

K.C. Stone
Managing Director, Head of Healthcare Investment Banking

Mr. Stone is a Managing Director and Head of BTIG's Healthcare Investment Banking Group. Previously, he was Managing Director and Head of Life Science Investment Banking at Wedbush-PacGrow. Mr. Stone has a long history of working with emerging growth companies from seed-stage to publicly traded institutions, and with the investors who fund them. He led the effort to finance and provide advisory services to numerous public and private companies through his previous roles as Managing Director of the Private Placement Groups at Wedbush-PacGrow and Pacific Growth Equities. At Pacific Growth, Mr. Stone was a Senior Managing Director and Partner, and sat on the Executive and Commitment Committees. Prior to Pacific Growth, he ran the Venture Capital Services Group at Volpe Brown Whelan & Company. Mr. Stone has served on the Board of Directors of The Guardsmen, a San Francisco-based charitable organization that funds access to high-quality educational and outdoor activities for inner-city youth, and currently sits on the Board of Trustees for California Pacific Medical Center Foundation and on the Board of Governors of the Wine & Food Society of San Francisco. He graduated from the University of Colorado - Leeds School of Business.

Gregory Wade, Ph.D.
Managing Director, Healthcare Investment Banking

Dr. Wade is a Managing Director within BTIG's Healthcare Investment Banking Group. He has over 20 years of experience working with entrepreneurs in the biotechnology industry. Prior to joining BTIG, Dr. Wade was Head of Business Development at Pharmacyclics Inc., where he led the company's in-licensing activities and contributed to market research, strategy and competitive intelligence efforts. Previously, he spent 15 years in healthcare equity research, most recently as Managing Director at Wedbush PacGrow LifeSciences, the successor to Pacific Growth Equities. As an Equity Research Analyst, his coverage spanned nearly 60 companies across a diverse set of therapeutic areas including anti-infective, drug/device combinations, central nervous system, gastrointestinal, orthopedics oncology, pain, rare diseases and vaccines. Earlier in his career, Dr. Wade held roles in business development at Isis Pharmaceuticals and Procyon BioPharma. He was also an Associate at Helix Investments Canada Inc., while simultaneously undertaking his doctoral research at the University of Western Ontario, where he earned his Ph.D. in Physiology and Honors B.S. in Medical Biophysics. Dr. Wade serves on the Investment Committee of Canada's Healthcare Accelerator, Accel-Rx, and Clinical Advisory Board of the Center for Drug Research and Development.

FOLLOW US